Microvention, a wholly owned subsidiary of Terumo Corporation, today celebrated its 25-year anniversary in the neuroendovascular technologies industry.
The capstone of Microvention’s 25th anniversary celebration will include ‘Patient’s Day’. Timothy White, a neurosurgery chief resident and endovascular fellow at the Zucker School of Medicine at Hofstra/Northwell in Uniondale, USA, will provide an overview of a patient that was treated with Microvention products. Likewise, the patient will share her story of the positive impact and improvement to her life after being treated with multiple Microvention products, as per a press release.
Founded in 1997 by a handful of associates in a small facility in Southern California, the company is now a worldwide community with more than 3,000 global associates and distributors, and operates in over 70 countries with offices across the USA, Europe, Asia and Costa Rica.
Microvention has been focused on developing and marketing medical devices that improve patient lives through the treatment of strokes and aneurysms using its innovative products, the release adds. The company has launched over 30 products to date, expanding beyond cerebral aneurysms to include treatment for ischaemic stroke, carotid artery disease and neurovascular malformations.
As part of the anniversary ceremonies, the company will also add to a time capsule—which was built for Microvention’s 20-year anniversary in 2017—filled with various artifacts from the past 20 years of its history. The time capsule will be sealed and reopened in 2047 as a way of celebrating what the next 25 years may bring to the industry, and the company.
